BioSpace News Archive

Deals

Ginkgo Announces Public Offering of Class A Common Stock

Ginkgo Bioworks Holdings, Inc. today announced the sale of shares of its Class A common stock for gross proceeds of approximately $100 million to BTIG, LLC, as the underwriter in the registered public offering of those shares.

November 16, 2022
·
5 min read
Pharm Country

Thorne HealthTech to Participate in Evercore ISI HEALTHCONx Conference

Thorne HealthTech, Inc. today announced it will participate in a fireside chat and also meet with investors at the upcoming Evercore ISI HEALTHCONx Conference.

November 16, 2022
·
1 min read
Biotech Bay

Oscar Lambret Center in France Installs Second Accuray Radixact® System, the Hospital’s Fifth Accuray Radiation Therapy Delivery System

Accuray Incorporated (NASDAQ: ARAY) announced today that the Oscar Lambret Center in Lille, France has installed its second Radixact® System and the hospital’s fifth Accuray radiation therapy delivery system.

November 16, 2022
·
5 min read
Business

BrainsWay Reports Third Quarter 2022 Financial Results and Operational Highlights

BrainsWay Ltd. today reported third quarter 2022 financial results and provided an operational update.

November 16, 2022
·
12 min read
Business

Avid Bioservices Appoints Oksana Lukash as Vice President, People

Avid Bioservices, Inc. today announced the appointment of Oksana Lukash, as vice president, people.

November 16, 2022
·
2 min read
Business

Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project

Sunshine Biopharma Inc. today announced that it has entered into a collaboration agreement with one of North America’s leading lipid nanoparticle (“LNP”) companies.

November 16, 2022
·
3 min read
Deals

Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio

Kriya Therapeutics, Inc. today announced the acquisition of Redpin Therapeutics, Inc., a privately held biotechnology company developing regulatable gene therapies for intractable diseases of the nervous system.

November 16, 2022
·
4 min read
Biotech Beach

Ligand to Hold Investor and Analyst Day on December 13

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that it will hold an Investor and Analyst Day at The St. Regis New York on December 13, 2022, from 11:00 a.m. to 12:30 p.m. Eastern time (8:00 a.m. to 9:30 a.m. Pacific time).

November 16, 2022
·
2 min read
Business

NTT Research and Harvard Collaborate on Cardiovascular Bio Digital Twin

NTT Research, Inc., a division of NTT (TYO:9432), today announced that its Medical & Health Informatics (MEI) Lab has entered a three-year joint research agreement with the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS).

November 16, 2022
·
5 min read
Business

Horizon Therapeutics plc Announces Scientific Collaboration with Leading Research Institution to Advance Research in Autoimmunity and Inflammation

Horizon Therapeutics plc today announced that it has entered a multi-year scientific collaboration with Johns Hopkins University School of Medicine to identify new disease targets and develop therapies for patients with serious autoimmune and inflammatory conditions.

November 16, 2022
·
2 min read